CLINICAL COLLABORATION AND SUPPLY AGREEMENTClinical Collaboration and Supply Agreement • October 15th, 2021 • Immix Biopharma, Inc. • Pharmaceutical preparations • New York
This Clinical Collaboration and Supply Agreement (this “Agreement”), made as of August 20, 2021 (the “Effective Date”), is by and between IMMiX BioPharma, Inc., a corporation organized under the laws of the State of Delaware, having its place of business at 10573 West Pico Blvd., # 58, Los Angeles, CA 90064 (“Immix) and BeiGene, Switzerland GmbH, a Swiss corporation with a principal place of business at Aeschengraben 27, 21st Floor, 4051 Basel, Switzerland (“BeiGene”). BeiGene and Immix are each referred to herein as a “Party” and are collectively referred to as the “Parties”.
